The IHC showed that the IHS treatment increased the positive area of CD8 (p < 0.05) of tumor tissues, indicating an increase in the abundance of CD8+ cells in the tumor (Figure 4B); thus, IHS may mediate the tumor cell-killing effect by CD8+ T cells through increasing their abundance. The gene discussed is CD8A; the disease is neoplasm.